Mission Pharmacal Company:企業の戦略・SWOT・財務情報

MarketLineが発行した調査報告書(DATA904C13538)
◆英語タイトル:Mission Pharmacal Company - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C13538
◆発行会社(リサーチ会社):MarketLine
◆発行日:2019年2月
◆ページ数:37
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Mission Pharmacal Company – Strategy, SWOT and Corporate Finance Report
Summary

Mission Pharmacal Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Mission Pharmacal Company (Mission) is a privately-held pharmaceutical company. The company develops and manufactures over-the-counter (OTC), prescription products and dietary supplement products. Its products are used for various therapeutic areas, including women’s health, urology, pediatrics, dermatology, primary care and long-term care. These products are available under Aquoral, Avar, Binosto, Calcet Petites, CitraNatal, Dr. Smith’s, Eletone, Ferralet 90, Flowtuss, Hycofenix, Liquid KI, Maxilube, Oncovite, Thera-Gesic, Tindamax, Uribel and Utira-C brands. It operates manufacturing facilities in San Antonio and Boerne, and a commercial office in Doylestown, the US. The company has presence in the Americas, Europe, and Asia. Mission is headquartered in San Antonio, Texas, the US.

Scope

- Detailed information on Mission Pharmacal Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Mission Pharmacal Company in the form of a SWOT analysis
- An in-depth view of the business model of Mission Pharmacal Company including a breakdown and examination of key business segments
- Intelligence on Mission Pharmacal Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Mission Pharmacal Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Mission Pharmacal Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Mission Pharmacal Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Mission Pharmacal Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Mission Pharmacal Company: Company Overview
Mission Pharmacal Company: Overview and Key Facts
Mission Pharmacal Company: Overview
Mission Pharmacal Company: Key Facts
Mission Pharmacal Company: Key Employees
Mission Pharmacal Company: Key Employee Biographies
Mission Pharmacal Company: Major Products and Services
Mission Pharmacal Company: Company History
Mission Pharmacal Company: Locations and Subsidiaries
Mission Pharmacal Company: Key Competitors
Mission Pharmacal Company: Company Analysis
Mission Pharmacal Company: Business Description
Mission Pharmacal Company: SWOT Analysis
Mission Pharmacal Company: SWOT Overview
Mission Pharmacal Company: Strengths
Mission Pharmacal Company: Weaknesses
Mission Pharmacal Company: Opportunities
Mission Pharmacal Company: Threats
Mission Pharmacal Company: Corporate Financial Deals Activity
Mission Pharmacal Company: Financial Deals Overview
Mission Pharmacal Company: Targets and Partners
Mission Pharmacal Company: Top Deals 2015 – 2019YTD*
Mission Pharmacal Company: Mergers and Acquisitions
Mission Pharmacal Company: Partnership
Mission Pharmacal Company: Divestments
Mission Pharmacal Company: Recent Developments
Mission Pharmacal Company: News and Events Summary
Mission Pharmacal Company: Business Expansion
Mission Pharmacal Company: Contracts
Mission Pharmacal Company: Regulatory and Legal Events
Mission Pharmacal Company: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Mission Pharmacal Company: Key Facts
Table 2: Mission Pharmacal Company: Key Employees
Table 3: Mission Pharmacal Company: Company History
Table 4: Mission Pharmacal Company: Locations and Subsidiaries
Table 5: Mission Pharmacal Company: Key Competitors
Table 6: Mission Pharmacal Company: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Mission Pharmacal Company: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Mission Pharmacal Company: Targets and Partners
Table 9: Mission Pharmacal Company: Top Deals 2015 - 2019YTD*
Table 10: Mission Pharmacal Company: M&A Volume and Value Trend (2015 - YTD*2019)
Table 11: Mission Pharmacal Company: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 12: Mission Pharmacal Company: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 13: Mission Pharmacal Company: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 14: Mission Pharmacal Company: News and Events Summary
Table 15: Mission Pharmacal Company: Business Expansion
Table 16: Mission Pharmacal Company: Contracts
Table 17: Mission Pharmacal Company: Regulatory and Legal Events
Table 18: Mission Pharmacal Company: Strategy and Operations

List of Figures
Figure 1: Mission Pharmacal Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Mission Pharmacal Company: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Mission Pharmacal Company: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 4: Mission Pharmacal Company: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 5: Mission Pharmacal Company: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 6: Mission Pharmacal Company: Divestments Volume and Value Trend (2015 - YTD*2019)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Mission Pharmacal Company:企業の戦略・SWOT・財務情報(Mission Pharmacal Company - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆